12:59 PM EDT, 10/20/2025 (MT Newswires) -- Kenvue ( KVUE ) said Sunday it urged the US Food and Drug Administration to reject a citizen petition for an autism warning on Tylenol, the over-the-counter drug to treat pain and reduce fever, including during pregnancy.

The drugmaker said the petition for labeling changes should be denied because there is no causal link between Tylenol use and autism in children.

Kenvue ( KVUE ) said the current warning that directs pregnant women to consult health professionals before use "is the most conservative and appropriate approach based on the current scientific evidence and in the interest of public health."

The FDA didn't immediately respond to a request for comment from MT Newswires.

Price: 15.10, Change: -0.19, Percent Change: -1.22